Myelodysplastic syndromes and chronic myelomonocytic leukemia (CMML) are seen as a mutations in genes encoding epigenetic modifiers and aberrant DNA methylation. method of predicting response at medical diagnosis. While somatic mutations didn’t differentiate responders from non-responders we determined Stattic 167 differentially methylated locations (DMRs) of DNA at baseline that recognized responders from non-responders using next-generation… Continue reading Myelodysplastic syndromes and chronic myelomonocytic leukemia (CMML) are seen as a